Blue Cone Monochromatism (BCM)
A rare inherited retinal condition that affects the function of cone cells, the specialised cells in the retina responsible for colour vision and detailed vision in bright light.
Understanding Blue Cone Monochromatism
Blue Cone Monochromatism (BCM) is a rare inherited retinal condition that affects the function of cone cells, the specialised cells in the retina responsible for colour vision and detailed vision in bright light.
People with BCM have little or no functioning red (L-cone) and green (M-cone) photoreceptor activity, meaning they rely mainly on blue-sensitive (S-cone) cells and rod cells for vision.
The condition is present from birth and can cause reduced visual acuity, severe colour vision impairment, sensitivity to light, and involuntary eye movements. Vision is often reduced from early childhood and remains relatively stable, although some individuals may experience progressive changes over time.
BCM is caused by changes in genes involved in the development and function of cone photoreceptors. Advances in genetic testing, retinal imaging, and gene-based therapies are increasing understanding of the condition and creating new opportunities for future treatments.
Retina International works with people affected by BCM, inherited retinal disease communities, researchers, clinicians, and partners worldwide to improve awareness, advance research, and ensure patient experiences inform the future of retinal healthcare.
What is Blue Cone Monochromatism?
Blue Cone Monochromatism is a rare inherited retinal disease affecting the cone cells of the retina.
The retina contains two main types of light-sensitive cells:
Rod cells
Rod cells help with:
- Vision in low light
- Night vision
- Detecting movement
Cone cells
Cone cells support:
- Sharp central vision
- Colour vision
- Detailed vision in daylight
There are three types of cone cells:
- L-cones – sensitive to longer wavelengths (red light)
- M-cones – sensitive to medium wavelengths (green light)
- S-cones – sensitive to shorter wavelengths (blue light)
In BCM, the L- and M-cone systems do not function correctly, leaving mainly S-cone and rod function.
This results in:
- Very limited colour perception
- Reduced visual clarity
- Light sensitivity
- Difficulty seeing in bright environments
BCM is sometimes classified as a cone dysfunction disorder or a form of inherited cone dystrophy.
3 cone types
BCM primarily affects L- and M-cone function, leaving S-cone and rod function relatively preserved.
X-linked
BCM is usually inherited through changes involving the X chromosome, particularly the OPN1LW and OPN1MW genes.
Present from birth
BCM typically causes early-onset reduced visual acuity, severe colour vision impairment, light sensitivity and nystagmus.
How Blue Cone Monochromatism can affect vision
Reduced visual acuity
People with BCM often have reduced sharpness of vision, particularly when looking at fine details.
This may affect:
- Reading
- Recognising faces
- Seeing distant objects
Severe colour vision impairment
Because red and green cone function is affected, people with BCM experience significant difficulty distinguishing colours.
Many individuals perceive the world mainly in:
- Blue
- Yellow
- Grey tones
Light sensitivity (photophobia)
Bright light can cause discomfort and reduced visual function.
Many people with BCM prefer:
- Dim lighting
- Sunglasses
- Tinted lenses
Nystagmus
Involuntary eye movements are common, particularly during childhood.
Reduced vision in bright conditions
Unlike typical vision, where daylight improves sight, people with BCM may experience worsening vision in bright environments due to cone dysfunction.
Reduced contrast sensitivity
Some individuals have difficulty distinguishing objects from their background.
Identifying Blue Cone Monochromatism
Eye examination
An ophthalmologist evaluates vision and examines the retina.
Visual acuity testing
Measures clarity of vision.
Colour vision testing
Specialised tests assess colour perception and can identify patterns consistent with BCM.
Optical coherence tomography (OCT)
OCT provides detailed images of retinal layers and can show changes affecting cone cells.
Fundus autofluorescence (FAF)
FAF imaging can help assess retinal health and identify areas of change.
Electroretinography (ERG)
ERG measures electrical responses from retinal cells.
In BCM, specialised ERG testing can demonstrate reduced or absent cone responses.
Genetic testing
Genetic testing can identify changes affecting cone opsin genes and confirm diagnosis.
A genetic diagnosis can help:
- Provide clarity about the condition
- Support family counselling
- Identify eligibility for research studies
- Improve understanding of disease progression
Supporting vision and improving quality of life
Managing light sensitivity
People with BCM may benefit from:
- Tinted glasses
- Light-filtering lenses
- Reduced glare environments
- Adaptive lighting
Low vision support
Support may include:
- Magnification devices
- Digital accessibility tools
- Screen readers
- Vision rehabilitation
Educational support
Children with BCM may benefit from:
- Classroom accommodations
- Accessible learning materials
- Specialist vision support
Workplace support
Adults may benefit from:
- Workplace adjustments
- Assistive technologies
- Flexible approaches to visual tasks
Emerging therapies
Research is exploring treatments aimed at restoring cone function, including:
- Gene therapy
- Gene editing approaches
- Retinal cell therapies
Supporting independence and quality of life
Living with BCM involves adapting to reduced colour vision, light sensitivity, and reduced visual acuity.
People affected may experience challenges with:
- Education
- Employment
- Driving eligibility
- Navigation
- Daily activities
Support strategies may include:
- Using technology to identify colours
- Adapting lighting environments
- Accessing vision rehabilitation
- Connecting with others living with inherited retinal conditions
Because BCM is present from birth, early support can help children develop effective strategies for learning and independence.
The lived experiences of people with BCM are essential in shaping research priorities and improving support services.
Advancing the future of BCM treatment
Gene therapy
Researchers are investigating whether gene-based approaches can restore functional cone responses.
Potential approaches include:
- Delivering functional copies of affected genes
- Modifying genetic pathways involved in cone development
Retinal imaging advances
New imaging techniques help researchers:
- Understand cone cell loss
- Monitor disease progression
- Measure treatment effects
Natural history studies and registries
Long-term studies help researchers understand:
- How vision changes over time
- Which outcomes matter most to patients
- How clinical trials should be designed
Clinical trials
Research studies are exploring new therapies for inherited cone disorders, including BCM.
Learn About Clinical TrialsInformation and community support
Take the Next Step
Blue Cone Monochromatism demonstrates the importance of understanding cone biology, genetic causes of vision loss, and patient-centred innovation in inherited retinal disease research.
Through collaboration between people affected by BCM, families, researchers, clinicians, and organisations worldwide, progress continues towards improved diagnosis, better support, and future therapies that may restore or preserve vision.
